Cyclerion Therapeutics, Inc.

Analysis for Ticker: CYCN

Cyclerion Therapeutics is a company that claims to develop medical treatments for the brain, specifically a drug for depression called CYC-126. But the math reveals a different operation entirely. This is a business that has lost 271$ million since it started and survives by eating itself. Think of it like a lemonade stand that has no lemons and no customers, yet pays its one single employee millions of dollars while selling pieces of the wooden stand to passersby just to keep the lights on. By 04/2026, the people who actually owned the company were told they would soon own only 1,5% of it, while a new group of rich outsiders takes 98,5%. It is a machine designed to move money from the pockets of regular people into the pockets of lawyers, consultants, and executives.